Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

103.15 

1.71 1.7%

as of Aug 21 '19

52 Week Range:

78.95 111.54


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 18.43
21.77
23.63
22.38
26.29
26.69
29.04
32.09
34.04
35.51
39.39
growth rate 18.1% 8.5% -5.3% 17.5% 1.5% 8.8% 10.5% 6.1% 4.3% 10.9%
Earnings BIT 1,020.00
1,230.00
1,180.00
856.23
1,233.10
1,510.00
1,119.00
1,204.00
1,228.00
1,284.00
1,225.00
growth rate 20.6% -4.1% -27.4% 44.0% 22.5% -25.9% 7.6% 2.0% 4.6% -4.6%
Avg.PE 16.08
15.55
13.30
19.80
14.86
10.08
18.39
14.23
21.58
18.48
16.60
growth rate -3.3% -14.5% 48.9% -25.0% -32.2% 82.4% -22.6% 51.7% -14.4% -10.2%
ROA 6.85
8.59
8.44
5.28
5.95
9.28
5.89
7.12
6.40
7.46
6.82
growth rate 25.4% -1.8% -37.4% 12.7% 56.0% -36.5% 20.9% -10.1% 16.6% -8.6%
ROE 16.78
19.20
17.97
12.18
14.08
20.86
13.43
15.72
13.79
16.11
14.46
growth rate 14.4% -6.4% -32.2% 15.6% 48.2% -35.6% 17.1% -12.3% 16.8% -10.2%
ROIC 10.23
11.88
11.54
7.89
8.61
12.78
8.70
9.85
8.73
10.37
9.74
growth rate 16.1% -2.9% -31.6% 9.1% 48.4% -31.9% 13.2% -11.4% 18.8% -6.1%
Cur. Ratio 1.22
1.59
1.32
0.90
1.49
1.22
0.93
1.28
1.56
1.24
0.94
growth rate 30.3% -17.0% -31.8% 65.6% -18.1% -23.8% 37.6% 21.9% -20.5% -24.2%
Quick Ratio 0.89
1.29
1.07
0.69
1.11
0.92
0.66
0.88
1.31
1.00
0.77
growth rate 44.9% -17.1% -35.5% 60.9% -17.1% -28.3% 33.3% 48.9% -23.7% -23.0%
Leverage 2.33
2.15
2.11
2.52
2.23
2.27
2.30
2.13
2.18
2.13
2.11
growth rate -7.7% -1.9% 19.4% -11.5% 1.8% 1.3% -7.4% 2.4% -2.3% -0.9%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 832.90
827.30
845.30
1,059.78
867.00
852.00
932.00
933.00
931.00
931.00
1,015.00
growth rate -0.7% 2.2% 25.4% -18.2% -1.7% 9.4% 0.1% -0.2% 0.0% 9.0%
Acct.Payable 906.76
203.50
258.00
257.00
279.00
231.00
224.00
222.00
growth rate -77.6% 26.8% -0.4% 8.6% -17.2% -3.0% -0.9%
Cur.Assets 1,496.80
1,679.40
1,605.40
1,401.26
1,561.00
1,383.00
1,603.00
1,501.00
1,531.00
1,306.00
1,390.00
growth rate 12.2% -4.4% -12.7% 11.4% -11.4% 15.9% -6.4% 2.0% -14.7% 6.4%
Total Assets 8,403.80
8,563.60
8,527.60
9,313.38
9,283.90
8,948.00
9,857.00
9,962.00
10,100.00
10,503.00
11,003.00
growth rate 1.9% -0.4% 9.2% -0.3% -3.6% 10.2% 1.1% 1.4% 4.0% 4.8%
Cash 253.90
534.30
449.30
164.89
295.60
187.00
192.00
133.00
359.00
137.00
135.00
growth rate 110.4% -15.9% -63.3% 79.3% -36.7% 2.7% -30.7% 169.9% -61.8% -1.5%
Inventory 102.10
91.40
76.60
89.13
93.10
91.00
110.00
84.00
82.00
95.00
99.00
growth rate -10.5% -16.2% 16.4% 4.5% -2.3% 20.9% -23.6% -2.4% 15.9% 4.2%
Cur.Liabilities 1,224.80
1,059.20
1,214.30
1,561.16
1,047.60
1,132.00
1,709.00
1,173.00
981.00
1,057.00
1,485.00
growth rate -13.5% 14.6% 28.6% -32.9% 8.1% 51.0% -31.4% -16.4% 7.8% 40.5%
Liabilities 4,798.90
4,574.00
4,494.20
5,620.51
5,120.80
5,000.00
5,527.00
5,179.00
5,363.00
5,468.00
5,659.00
growth rate -4.7% -1.7% 25.1% -8.9% -2.4% 10.5% -6.3% 3.6% 2.0% 3.5%
LT Debt 3,078.10
2,936.80
2,641.20
3,370.52
3,354.20
3,120.00
3,252.00
3,498.00
3,816.00
3,837.00
3,490.00
growth rate -4.6% -10.1% 27.6% -0.5% -7.0% 4.2% 7.6% 9.1% 0.6% -9.0%
Equity 3,604.90
3,989.60
4,033.50
3,692.87
4,163.00
3,948.00
4,301.00
4,684.00
4,628.00
4,921.00
5,216.00
growth rate 10.7% 1.1% -8.4% 12.7% -5.2% 8.9% 8.9% -1.2% 6.3% 6.0%
Common Shares 196.00
188.00
177.00
160.00
160.00
153.00
145.00
2.00
2.00
2.00
2.00
growth rate -4.1% -5.9% -9.6% 0.0% -4.4% -5.2% -98.6% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 0.00
0.00
0.00
161.00
182.00
231.00
308.00
263.00
293.00
252.00
383.00
growth rate 13.0% 26.9% 33.3% -14.6% 11.4% -14.0% 52.0%
Cash Dividends 110.90
110.30
108.10
101.00
145.90
217.00
187.00
212.00
223.00
247.00
266.00
growth rate -0.5% -2.0% -6.6% 44.5% 48.7% -13.8% 13.4% 5.2% 10.8% 7.7%
Cash From OA 1,063.00
997.40
1,118.00
895.00
1,187.20
652.00
944.00
821.00
1,116.00
1,175.00
1,200.00
growth rate -6.2% 12.1% -20.0% 32.7% -45.1% 44.8% -13.0% 35.9% 5.3% 2.1%
FCF per Share 4.34
4.42
5.15
4.35
6.28
3.89
3.78
4.03
5.34
6.14
6.56
growth rate 1.8% 16.5% -15.5% 44.4% -38.1% -2.8% 6.6% 32.5% 15.0% 6.8%
Sale Purchase of Stock -798.00
-200.00
-1,037.00
78.00
60.00
73.00
130.00
growth rate 0.0% 0.0% 100.0% -23.1% 21.7% 78.1%
FCF 850.00
830.00
913.00
734.00
1,005.00
421.00
630.00
547.00
776.00
923.00
817.00
growth rate -2.4% 10.0% -19.6% 36.9% -58.1% 49.6% -13.2% 41.9% 18.9% -11.5%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 7,249.40
7,455.20
7,368.90
7,392.00
7,382.60
7,146.00
7,435.00
7,493.00
7,214.00
7,402.00
7,531.00
growth rate 2.8% -1.2% 0.3% -0.1% -3.2% 4.0% 0.8% -3.7% 2.6% 1.7%
Op.Income 1,222.40
1,359.10
1,295.50
494.00
666.50
883.00
1,119.00
1,204.00
1,228.00
1,284.00
1,225.00
growth rate 11.2% -4.7% -61.9% 34.9% 32.5% 26.7% 7.6% 2.0% 4.6% -4.6%
IBT 1,019.00
1,227.90
1,184.30
849.00
1,068.40
1,348.00
849.00
1,126.00
1,125.00
1,065.00
970.00
growth rate 20.5% -3.6% -28.3% 25.8% 26.2% -37.0% 32.6% -0.1% -5.3% -8.9%
Net Income 581.50
729.10
720.90
494.00
555.70
849.00
556.00
709.00
645.00
772.00
736.00
growth rate 25.4% -1.1% -31.5% 12.5% 52.8% -34.5% 27.5% -9.0% 19.7% -4.7%
EPS 2.97
3.87
4.05
2.92
3.46
5.54
3.81
4.87
4.51
5.50
5.29
growth rate 30.3% 4.7% -27.9% 18.5% 60.1% -31.2% 27.8% -7.4% 22.0% -3.8%
Gross Profit 2,993.30
3,133.80
3,051.70
3,029.00
3,229.70
2,820.00
2,848.00
2,901.00
2,638.00
2,733.00
2,673.00
growth rate 4.7% -2.6% -0.7% 6.6% -12.7% 1.0% 1.9% -9.1% 3.6% -2.2%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 330.00
311.00
271.00
260.00
327.00
growth rate -5.8% -12.9% -4.1% 25.8%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 1,058.00
1,100.00
1,015.00
1,081.00
1,091.00
growth rate 4.0% -7.7% 6.5% 0.9%
Acct.Payable 934.00
1,067.00
222.00
1,002.00
933.00
growth rate 14.2% -79.2% 351.4% -6.9%
Cur.Assets 1,415.00
1,603.00
1,390.00
1,778.00
1,566.00
growth rate 13.3% -13.3% 27.9% -11.9%
Total Assets 10,747.00
10,986.00
11,003.00
11,937.00
11,760.00
growth rate 2.2% 0.2% 8.5% -1.5%
Cash 132.00
263.00
135.00
464.00
273.00
growth rate 99.2% -48.7% 243.7% -41.2%
Inventory 91.00
95.00
99.00
98.00
105.00
growth rate 4.4% 4.2% -1.0% 7.1%
Cur.Liabilities 1,262.00
1,389.00
1,485.00
2,282.00
1,904.00
growth rate 10.1% 6.9% 53.7% -16.6%
Liabilities 5,408.00
5,544.00
5,659.00
6,519.00
6,175.00
growth rate 2.5% 2.1% 15.2% -5.3%
LT Debt 3,493.00
3,489.00
3,490.00
3,176.00
3,175.00
growth rate -0.1% 0.0% -9.0% 0.0%
Equity 5,223.00
5,317.00
5,216.00
5,290.00
5,459.00
growth rate 1.8% -1.9% 1.4% 3.2%
Common Shares 2.00
2.00
2.00
2.00
2.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 78.00
81.00
151.00
47.00
85.00
growth rate 3.9% 86.4% -68.9% 80.9%
Cash Dividends 68.00
69.00
68.00
72.00
71.00
growth rate 1.5% -1.5% 5.9% -1.4%
Cash From OA 323.00
402.00
295.00
275.00
321.00
growth rate 24.5% -26.6% -6.8% 16.7%
Sale Purchase of Stock 37.00
growth rate
FCF 245.00
321.00
144.00
228.00
236.00
growth rate 31.0% -55.1% 58.3% 3.5%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 1,919.00
1,889.00
1,839.00
1,891.00
1,953.00
growth rate -1.6% -2.7% 2.8% 3.3%
Op.Income 330.00
311.00
271.00
260.00
327.00
growth rate -5.8% -12.9% -4.1% 25.8%
IBT 275.00
275.00
179.00
226.00
282.00
growth rate 0.0% -34.9% 26.3% 24.8%
Net Income 219.00
213.00
127.00
164.00
226.00
growth rate -2.7% -40.4% 29.1% 37.8%
EPS
growth rate
Gross Profit 690.00
678.00
624.00
658.00
699.00
growth rate -1.7% -8.0% 5.5% 6.2%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (35.78)

YOY Growth Grade:

E (29.46)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 18.92 19.75 14.53
EPS / Growth 9.4% 5.22 9.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.5% 7.7% 7.7%
Future PE 9.08 16.31 16.31
Future EPS 8.14 11.01 11.01
Value Price
MOS %
18.27
-82.3%
44.37
-57.0%
44.37
-57.0%
MOS Price 9.14 22.18 22.18
IRT 13.95 11.84 11.84

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.